AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2026 Earnings Call Transcript May 12, 2026
Operator: Good afternoon, and welcome to AbCellera’s Q1 2026 Business Update Conference Call. My name is Ben, and I will facilitate the audio portion of today’s interactive broadcast. [Operator Instructions] At this time, I would like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance Officer. You may proceed.
Tryn Stimart: Thank you. Hello, everyone. Thank you for joining us for...
